Journal Article

Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals

Ridsdale, Heidi A, Wall, Emma, Prescott, Gordon, Logan, Sarah, Dehbi, Hakim-Moulay, Chauhan, Alisha, Astin, Ronan, Brown, Jeremy S, Banerjee, Amitava, Purcell, Helen, Brennan, Ewen, Porter, Joanna, Cone, Stephen, Zandi, Michael, Hishmeh, Lyth, Marks, Michael, Bell, Robert, McNamara, Patricia, Attree, Emily, Evans, Rebecca, Livingston, Rebecca, Roy, Kay, Heightman, Melissa, Hillman, Toby E, Denneny, Emma, Prashar, Jai, Mehta, Puja

2021

Overview

IntroductionPost-COVID-19 complications require simultaneous characterisation and management to plan policy and health system responses. We describe the 12-month experience of the first UK dedicated post-COVID-19 clinical service to include hospitalised and non-hospitalised patients.MethodsIn a single-centre, observational analysis, we report the demographics, symptoms, comorbidities, investigations, treatments, functional recovery, specialist referral and rehabilitation of 1325 individuals assessed at the University College London Hospitals post-COVID-19 service between April 2020 and April 2021, comparing by referral route: posthospitalised (PH), non-hospitalised (NH) and post emergency department (PED). Symptoms associated with poor recovery or inability to return to work full time were assessed using multivariable logistic regression.Results1325 individuals were assessed (PH: 547, 41.3%; PED: 212, 16%; NH: 566, 42.7%). Compared with the PH and PED groups, the NH group were younger (median 44.6 (35.6–52.8) years vs 58.3 (47.0–67.7) years and 48.5 (39.4–55.7) years), more likely to be female (68.2%, 43.0% and 59.9%), less likely to be of ethnic minority (30.9%, 52.7% and 41.0%) or seen later after symptom onset (median (IQR): 194 (118–298) days, 69 (51–111) days and 76 (55–128) days; all p<0.0001). All groups had similar rates of onward specialist referral (NH 18.7%, PH 16.1% and PED 18.9%, p=0.452) and were more likely to require support for breathlessness (23.7%, 5.5% and 15.1%, p<0.001) and fatigue (17.8%, 4.8% and 8.0%, p<0.001). Hospitalised patients had higher rates of pulmonary emboli, persistent lung interstitial abnormalities and other organ impairment. 716 (54.0%) individuals reported <75% optimal health (median 70%, IQR 55%–85%). Less than half of employed individuals could return to work full time at first assessment.ConclusionPost-COVID-19 symptoms were significant in PH and NH patients, with significant ongoing healthcare needs and utilisation. Trials of interventions and patient-centred pathways for diagnostic and treatment approaches are urgently required.

• Publisher: British Thoracic Society,BMJ Publishing Group LTD,BMJ Publishing Group
• Subject: clinical epidemiology / Consortia / Coronaviruses / COVID-19 / Delivery of Health Care / Electronic health records / Epidemiology / Ethnicity / Fatigue / Female / Hospitals / Humans / Infections / Male / Medical research / Minority Groups / Pandemics / Patient-centered care / Patients / Population / Post traumatic stress disorder / Prospective Studies / Respiratory Epidemiology / SARS-CoV-2 / Severe acute respiratory syndrome coronavirus 2 / University colleges / Variables / Web portals